Anticonvulsant activity of 3,4-dicarboxyphenylglycines in DBA/2 mice.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Neuropharmacology

• Publication date

  2001-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0028-3908(01)00002-8PMID 11311902
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• (S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord.

  2001cited by this paper
• Anticonvulsant activity of two metabotropic glutamate group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893).

  2000cited by this paper
• Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors

  2000cited by this paper
• Anticonvulsant activity of a metabotropic glutamate receptor 8 preferential agonist, (R,S)-4-phosphonophenylglycine.

  1999cited by this paper
• Neuropharmacology of AMPA and kainate receptors.

  1998cited by this paper
• Dicarboxyphenylglycines antagonize AMPA- but not kainate-induced depolarizations in neonatal rat motoneurones.

  1997cited by this paper
• Convulsant and anticonvulsant actions of agonists and antagonists of group III mGluRs.

  1996cited by this paper
• The effects of AMPA receptor antagonists on kindled seizures and on reflex epilepsy in rodents and primates.

  1992cited by this paper
• The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice.

  1991cited by this paper

• Psychosis of Epilepsy: An Update on Clinical Classification and Mechanism

  2025cites this paper
• Metabotropic glutamate receptors in GtoPdb v.2025.3

  2025cites this paper
• Proposed mechanisms of tau: relationships to traumatic brain injury, Alzheimer’s disease, and epilepsy

  2024cites this paper
• Multi-target Phenylpropanoids Against Epilepsy

  2024cites this paper
• Roles of metabotropic glutamate receptor 8 in neuropsychiatric and neurological disorders.

  2023cites this paper
• Audiogenic epileptic DBA/2 mice strain as a model of genetic reflex seizures and SUDEP

  2023cites this paper
• Cenobamate enhances the anticonvulsant effect of other antiseizure medications in the DBA/2 mouse model of reflex epilepsy.

  2023cites this paper
• Metabotropic glutamate receptors in GtoPdb v.2023.1

  2023cites this paper
• Metabotropic glutamate receptors in GtoPdb v.2021.3

  2021cites this paper
• The Modulation of Pain by Metabotropic Glutamate Receptors 7 and 8 in the Dorsal Striatum

  2019cites this paper
• Metabotropic glutamate receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Structural Basis for ( S)-3,4-Dicarboxyphenylglycine (DCPG) As a Potent and Subtype Selective Agonist of the mGlu8 Receptor.

  2018cites this paper
• Selective agonism of mGlu8 receptors by (S)-3,4-dicarboxyphenylglycine does not affect sleep stages in the rat

  2017cites this paper
• Group III mGlu Receptor Agonist, ACPT-I, Exerts Potential Neuroprotective Effects In Vitro and In Vivo

  2014cites this paper
• Group III Metabotropic Glutamate Receptors: Pharmacology, Physiology and Therapeutic Potential

  2014cites this paper
• Neuroprotective and symptomatic effects of targeting group III mGlu receptors in neurodegenerative disease

  2014cites this paper
• Metabotropic glutamatergic receptors and their ligands in drug addiction.

  2014cites this paper
• Supraspinal metabotropic glutamate receptor subtype 8: a switch to turn off pain

  2014cites this paper
• Group III and subtype 4 metabotropic glutamate receptor agonists: discovery and pathophysiological applications in Parkinson's disease.

  2013cites this paper
• Author ' s personal copy Invited review Group III and subtype 4 metabotropic glutamate receptor agonists : Discovery and pathophysiological applications in Parkinson ’ s disease

  2013cites this paper
• Characterisation of an mGlu8 receptor-selective agonist and antagonist in the lateral and medial perforant path inputs to the dentate gyrus.

  2013cites this paper
• Orthosteric versus allosteric GPCR activation: the great challenge of group-III mGluRs.

  2012cites this paper
• GLUTAMATE RECEPTORS; FROM BASIC PHARMACOLOGY TO CLINICAL APPLICATIONS

  2012cites this paper
• Participation of metabotropic glutamate receptors in pentetrazol‐induced kindled seizure

  2011influential citation
• A Review: Stereochemical consideration and eudismic ratio in chiral drug development

  2010cites this paper
• Metabotropic glutamate receptors in the control of neuronal activity and as targets for development of anti-epileptogenic drugs.

  2009cites this paper
• Anticonvulsant and neuroprotective effect of (S)-3,4-dicarboxyphenylglycine against seizures induced in immature rats by homocysteic acid.

  2008cites this paper
• Group III Metabotropic Glutamate Receptors (mGlu4, mGlu6, mGlu7, and mGlu8)

  2008cites this paper
• Evaluation of the mGlu8 receptor as a putative therapeutic target in schizophrenia.

  2007cites this paper
• Metabotropic glutamate receptors

  2007cites this paper
• Anticonvulsive Effect of a Selective mGluR8 Agonist (S)‐3,4‐Dicarboxyphenylglycine (S‐3,4‐DCPG) in the Mouse Pilocarpine Model of Status Epilepticus

  2007cites this paper
• An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats

  2007cites this paper
• O papel dos canais iônicos nas epilepsias e considerações sobre as drogas antiepilépticas: uma breve revisão

  2007cites this paper
• Metabotropic Glutamate Receptors

  2007cites this paper
• Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy.

  2006cites this paper
• Group III metabotropic glutamate receptors as potential targets in the treatment of Parkinson's disease

  2006cites this paper
• Lack of the antianxiety-like effect of (S)-3,4-DCPG, an mGlu8 receptor agonist, after central administration in rats.

  2005cites this paper
• Agonists and antagonists of metabotropic glutamate receptors: anticonvulsants and antiepileptogenic agents?

  2005cites this paper
• Targeting the metabotropic glutamate receptor mGluR4 for the treatment of diseases of the central nervous system.

  2005cites this paper
• Ionotropic and metabotropic glutamate receptor structure and pharmacology

  2005cites this paper
• Suppression of alcohol self-administration and cue-induced reinstatement of alcohol seeking by the mGlu2/3 receptor agonist LY379268 and the mGlu8 receptor agonist (S)-3,4-DCPG.

  2005cites this paper
• Characterization of the anticonvulsant profile of valpromide derivatives.

  2004cites this paper
• In vivo modulation of extracellular hippocampal glutamate and GABA levels and limbic seizures by group I and II metabotropic glutamate receptor ligands

  2004cites this paper
• Potential antipsychotic and extrapyramidal effects of (R,S)-3,4-dicarboxyphenylglycine [(R,S)-3,4-DCPG], a mixed AMPA antagonist/mGluR8 agonist.

  2004cites this paper
• Increased c-Fos expression in the centromedial nucleus of the thalamus in metabotropic glutamate 8 receptor knockout mice following the elevated plus maze test.

  2003cites this paper
• Systemic administration of the potent mGlu8 receptor agonist (S)-3,4-DCPG induces c-Fos in stress-related brain regions in wild-type, but not mGlu8 receptor knockout mice.

  2003cites this paper
• Anticonvulsant dicarboxyphenylglycines differentially modulate excitatory amino acid release in the rat cerebral cortex.

  2003cites this paper
• Expression and Cell Distribution of Group I and Group II Metabotropic Glutamate Receptor Subtypes in Taylor‐type Focal Cortical Dysplasia

  2003cites this paper
• Glutamate metabotropic receptors as targets for drug therapy in epilepsy.

  2003cites this paper
• N‐Salicyloyltryptamine, a new anticonvulsant drug, acts on voltage‐dependent Na+, Ca2+, and K+ ion channels

  2003cites this paper
• Phenylglycine derivatives as antagonists of group III metabotropic glutamate receptors expressed on neonatal rat primary afferent terminals

  2003cites this paper
• Seizures induced by homocysteic acid in immature rats are prevented by group III metabotropic glutamate receptoragonist (R,S)-4-phosphonophenylglycine.

  2003cites this paper
• Pre-and Postsynaptic Sites of Action of mGluR 8 a in the Mammalian Retina

  2002cites this paper
• Pre- and Postsynaptic Sites of Action of mGluR8a in the mammalian retina.

  2002cites this paper
• Group III mGlu receptor agonists potentiate the anticonvulsant effect of AMPA and NMDA receptor block.

  2002cites this paper
• Modulation of lateral perforant path excitatory responses by metabotropic glutamate 8 (mGlu8) receptors.

  2002cites this paper
• Increased anxiety-related behavior in mice deficient for metabotropic glutamate 8 (mGlu8) receptor.

  2002cites this paper